Patients With Relapsed Cll clinical trials

Explore recruiting patients with relapsed cll clinical trials.

Recruiting patients with relapsed cll studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Patients With Relapsed Cll trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

HOVON 159 CLL: REtreatment with VEnetoclax and Acalabrutinib after venetoclax Limited duration (REVEAL) A prospective, multicenter, phase-II trial of venetoclax plus acalabrutinib in patients who have relapsed after first line venetoclax + anti-CD20 mAb treatment for chronic lymphocytic leukemia (CLL or SLL)

Belgium, Netherlands, Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Patients With Relapsed Cll trials by city

Patients With Relapsed Cll in Toronto Patients With Relapsed Cll in Vancouver Patients With Relapsed Cll in Montreal Patients With Relapsed Cll in Calgary Patients With Relapsed Cll in Edmonton Patients With Relapsed Cll in Ottawa Patients With Relapsed Cll in Winnipeg Patients With Relapsed Cll in Quebec City Patients With Relapsed Cll in Hamilton Patients With Relapsed Cll in Kitchener Patients With Relapsed Cll in London Patients With Relapsed Cll in Halifax Patients With Relapsed Cll in New York Patients With Relapsed Cll in Los Angeles Patients With Relapsed Cll in Chicago Patients With Relapsed Cll in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease